What is Evusheld and how can it help immunocompromised people avoid symptomatic COVID-19 infections? episode artwork

EPISODE · Sep 13, 2022 · 9 MIN

What is Evusheld and how can it help immunocompromised people avoid symptomatic COVID-19 infections?

from The Morning Show with Devon Peacock · host Corus Radio

On April 14, 2022, Health Canada approved AstraZeneca’s antibody combination, known as Evusheld, to prevent symptomatic COVID-19 infection in immunocompromised people. Infectious disease expert Dr. Isaac Bogoch joins Devon Peacock to discuss.

NOW PLAYING

What is Evusheld and how can it help immunocompromised people avoid symptomatic COVID-19 infections?

0:00 9:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Morning Show with Devon Peacock?

This episode is 9 minutes long.

When was this The Morning Show with Devon Peacock episode published?

This episode was published on September 13, 2022.

What is this episode about?

On April 14, 2022, Health Canada approved AstraZeneca’s antibody combination, known as Evusheld, to prevent symptomatic COVID-19 infection in immunocompromised people. Infectious disease expert Dr. Isaac Bogoch joins Devon Peacock to discuss.

Can I download this The Morning Show with Devon Peacock episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!